Codes / ICD10CM / H04.033

H04.033 Chronic enlargement of bilateral lacrimal glands

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Chronic enlargement of bilateral lacrimal glands

Summary

Chronic enlargement of bilateral lacrimal glands refers to a persistent, non-acute increase in the size of both lacrimal glands, which are responsible for tear production. This condition is characterized by long-term or recurrent symptoms affecting both eyes and may be associated with underlying causes that require ongoing evaluation and management.

Causes

Chronic enlargement of bilateral lacrimal glands can result from persistent inflammatory processes, such as chronic infections (viral or bacterial) or autoimmune conditions like Sjögren's syndrome. In some cases, the enlargement may be idiopathic, meaning no specific cause is identified. Repeated or unresolved acute episodes of inflammation can also contribute to the development of chronic enlargement.

Risk Factors

Individuals with a history of autoimmune disorders, particularly Sjögren's syndrome, are at increased risk. Chronic infections affecting the lacrimal glands or surrounding tissues may predispose to this condition. Prolonged exposure to irritants or unresolved inflammatory processes can also contribute to the risk.

Symptoms

  • Persistent swelling in the outer portion of the upper eyelids of both eyes.
  • Chronic eyelid redness and tenderness.
  • Ongoing pain or discomfort in the eye region.
  • Changes in tear production, such as increased or decreased tearing.
  • Visual disturbances or discomfort due to gland enlargement.

Diagnosis

Diagnosis typically involves a thorough clinical examination, including assessment of eyelid swelling, tenderness, and tear production. Imaging studies, such as ultrasound or MRI, may be used to evaluate gland size and rule out other conditions. Laboratory tests, including autoimmune markers, may be ordered if an underlying systemic condition is suspected.

Treatment Options

Treatment focuses on addressing the underlying cause, such as managing autoimmune conditions or treating chronic infections. Symptomatic relief may include anti-inflammatory medications, lubricating eye drops, or warm compresses. In severe cases, surgical intervention to reduce gland size or address complications may be considered.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Chronic cases may require long-term management to control symptoms and prevent complications. Regular follow-up with an ophthalmologist is recommended to monitor gland size, tear production, and overall eye health.

Complications

Potential complications include chronic dry eye, corneal damage from inadequate tear production, or persistent discomfort. In rare cases, untreated enlargement may lead to vision impairment or other ocular issues.

Lifestyle & Prevention

Maintaining good eye hygiene, avoiding irritants, and managing underlying conditions (e.g., autoimmune disorders) can help reduce risk. Using lubricating eye drops as needed and protecting the eyes from environmental factors may alleviate symptoms.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new symptoms develop, or there is significant pain, vision changes, or swelling. Prompt evaluation is important to rule out serious underlying conditions or complications.

Tips for Medical Coders

Document the bilateral nature of the lacrimal gland enlargement and any associated findings (e.g., inflammation, systemic conditions) to support code assignment. Ensure clinical documentation aligns with the specific characteristics of the condition to accurately reflect the diagnosis.

Book a walkthrough

H04.033 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.